Formulation and evaluation of nasal mucoadhesive microparticles of diltiazem hydrochloride

International Journal of ChemTech Research

Volumn 1, Issue 4, 2009, Pages 1036-1042

  Dandge, Baby H ^a   Dehghan, M H G ^a  

^a Y B CHAVAN COLLEGE OF PHARMACY   (India)

Author keywords

Diltiazem; Factorial design; Mucoadhesive microparticles; Nasal mucosa

Indexed keywords

DILTIAZEM; ETHYL CELLULOSE; METHYLCELLULOSE;

ARTICLE; DRUG FORMULATION; GOAT; MEMBRANE MICROPARTICLE; MUCOADHESION; NONHUMAN;

EID: 77953414470     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. nd Edition, volume 50, Marcel Dekker Inc, 1992, 229-268
2. nd Edition, CRC press, 2004, 249-288
3. Illum L., Nasal drug delivery: new developments and strategies, Drug Discovery Today, Dec 2002 , 7(23) , 1184-1189
4. Merkus J., Guchelaar H., Bosch D.A. and Merkus F., Direct access of drugs to the human brain after intranasal drug administration? AAN Enterprises, Neurology, 2003, 60, 1669-1671
5. Chowdary K.P.R. and Srinivas L., Mucoadhesive drug delivery systems: A review of current status, Indian drugs, 2000, 37(9), 400-406
6. Khirsagar N.A., Drug delivery system, Indian Journal of Pharmacology, 2000, 32 , S54-S61
7. Chickering D.E. and Mathiowitz E, Bioadhesive drug delivery systems. Fundamentals, novel approaches, and developments, Marcel Dekker, New York, 1999, 1-10
8. Pereswetoff-Morath L., Microspheres as nasal drug delivery systems, Advanced Drug Delivery Reviews, 1998, 29, 185-194
9. st Edition, CBS publishers and distributors, 2002 , 417-454
10. nd Edition, Churchill Livingstone, 1992, 139-143.
11. th Edition, Churchill Livingstone, 2003, 193.
12. th Edition, pharmaceutical press, 2007, 1136-1138
13. Pavan B., Dalpiaz A., Ciliberti N., Biondi C., Manfredini C. and Vertuani S., Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach, Molecules, 2008, 13, 1035-1065
14. Nasal administration of calcium channel blockers for treatment of hypertension and other cardiovascular disorders, www.freepatentsonline.com, Patent no. 20050191245.
15. Delivery of anti-migraine compounds through an inhalation route, www.freepatentsonline.com, Patent no. 20040127481
16. Martinac A., Filipovic-Grcic J., Voinoch D., Perissutti B. and Franceschinis E., Development and bioadhesive properties of chitosan-ethyl cellulose microspheres for nasal delivery, International journal of pharmaceutics, 2005, 291, 69-77.
17. Das M.K. and Maurya D.P., Evaluation of diltiazem hydrochloride-loaded mucoadhesive microspheres prepared by emulsification-internal gelation technique, Acta Poloniae Pharmaceutica - Drug Research, 2008, 65 (2) , 249-259
18. Harikarnpakdee S., Lipipun V., Sutanthavibul N. and Ritthidej G.C., Spray dried mucoadhesive microspheres: Preparation and transport through nasal cell monolayer, AAPS Pharmscitech, 2005.
19. Tabassi S.A.S. and Razavi N., Preparation and characterization of albumin microspheres encapsulated with propranolol HCl, DARU, 2003, 11(4), 137-141.
20. Gavini E., Rassu G., Muzzarelli C., Cossu M. and Giunchedi P., Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide, European journal of Pharmaceutics and Biopharmaceutics, 2008, 68, 245-252
21. Jain S.K., Jain N.K., Gupta Y., Jain A., Jain D. and Chaurasia M., Mucoadhesive chitosan microspheres for non invasive and improved nasal delivery of insulin, Indian J. of Pharm. Sci., 2007, 69(4), 498-504
22. El-Hameed M.D.A. and Kellaway I.W., Preparation and in vitro characterization of mucoadhesive polymeric microspheres as intranasal delivery systems. European Journal of Pharmaceutics and Biopharmaceutics .1997, 44, 53-60.
23. Srivastava A., Ridhurkar D.N. and Wadhwa S., Floating microspheres of cimetidine: Formulation, characterization and in vitro evaluation, Acta Pharm, 2005, 55, 277-285.
24. Costa P. and Lobo J., Modeling and comparison of dissolution profiles, European Journal of Pharmaceutical Sciences, 2001, 13, 123-133.